Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 85187-37-7
2. Hustazol
3. Nitossil
4. Sekin
5. Cloperastine Fendizoate [jan]
6. Einecs 286-126-9
7. Hustazol (tn)
8. Unii-2m105305su
9. 2m105305su
10. 1-[2-[(4-chlorophenyl)-phenylmethoxy]ethyl]piperidine;2-(4-hydroxy-3-phenylbenzoyl)benzoic Acid
11. Chebi:31419
12. Cloperastine Fendizoate [mart.]
13. Cloperastine Fendizoate [who-dd]
14. O-((2'-hydroxy(1,1'-biphenyl)-4-yl)carbonyl)benzoic Acid, Compoundwith 1-(2-(4-chlorobenzhydryloxy)ethyl)piperidine (1:1)
15. Cloperastine Fendizoate (jan)
16. Cloperastine Fendizoate (mart.)
17. 1-(2-((4-chlorophenyl)(phenyl)methoxy)ethyl)piperidine 2-(6-hydroxy-[1,1'-biphenyl]-3-carbonyl)benzoate
18. 1-[2-[(4-chlorophenyl)phenylmethoxy]ethyl]-hydroxy[1,1'-biphenyl]-3-yl)carbonyl]benzoate Piperidine
19. Cloperastinefendizoate
20. Cloperastine Fendizoate (jp18)
21. Dtxsid001005645
22. Hy-b2179
23. Mfcd01661515
24. Akos040740750
25. Cs-7697
26. Bs-44741
27. Da-51971
28. Sy317590
29. D01569
30. E74488
31. J-520104
32. Q27254909
33. 1-[2-[(4-chlorophenyl)(phenyl)methoxy]ethyl]piperidine 2-(6-hydroxybiphenyl-3-carbonyl)benzoate
34. 2-(6-hydroxy[1,1'-biphenyl]-3-carbonyl)benzoic Acid--1-{2-[(4-chlorophenyl)(phenyl)methoxy]ethyl}piperidine (1/1)
Molecular Weight | 648.2 g/mol |
---|---|
Molecular Formula | C40H38ClNO5 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 10 |
Exact Mass | Da |
Monoisotopic Mass | Da |
Topological Polar Surface Area | 87.1 |
Heavy Atom Count | 47 |
Formal Charge | 0 |
Complexity | 772 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Cosma S.p.A.: FDA-approved API manufacturing with 300+ tons capacity, serving pharma and animal health industries worldwide.
Cosma S.p.A.: FDA-approved API manufacturing with 300+ tons capacity, serving pharma and animal health industries worldwide.
About the Company : Cosma S.p.A., established in 1977 in Bergamo, northern Italy, is the largest manufacturing site within the CFM group, with a 130,000L (130 m³) glass-lined reaction volume and over...
About the Company : Since its founding in 1962, MOEHS has produced Active Pharmaceutical Ingredients (APIs) for the international pharmaceutical industry. Thanks to a business history of more than 50 ...
About the Company : Aurore Life Sciences is a pure-play API manufacturer with a diverse portfolio of capabilities in delivering efficiencies to generic players globally. Founded in 2017 by a team with...
About the Company : Conscientia Industrial is a pharmaceutical company, mainly developing, manufacturing, marketing APIs (Active Pharmaceutical Ingredients), intermediates, fine chemicals in China. We...
About the Company : Flax Laboratories was established by a group of young and experienced professionals with the specific objective to develop and produce complex, small volume, technology driven bulk...
About the Company : A UK-based international Contract Research Organization (CRO) with more than 32 years of specialized knowledge in synthetic organic chemistry. Our clientele spans across large phar...
About the Company : Established in 1997, the PRECISE Group is a respected pharmaceutical company in India with an annual turnover of USD 40 million. Backed by a skilled regulatory team, a dedicated fo...
About the Company : Established in 1997, the PRECISE Group is a respected pharmaceutical company in India with an annual turnover of USD 40 million. Backed by a skilled regulatory team, a dedicated fo...
Regulatory Info :
Registration Country :
Brand Name : SEKISAN
Dosage Form : Syrup
Dosage Strength : 3.54MG/1ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country :
Packaging :
Regulatory Info :
Dosage : Syrup
Dosage Strength : 3.54MG/1ML
Brand Name : SEKISAN
Approval Date :
Application Number :
Registration Country :
Regulatory Info :
Registration Country :
Brand Name : Cinfatusina
Dosage Form : Oral Suspension
Dosage Strength : 3.54MG/1ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country :
Packaging :
Regulatory Info :
Dosage : Oral Suspension
Dosage Strength : 3.54MG/1ML
Brand Name : Cinfatusina
Approval Date :
Application Number :
Registration Country :
Regulatory Info :
Registration Country :
Brand Name : Quik
Dosage Form : Oral Suspension
Dosage Strength : 200ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country :
Packaging :
Regulatory Info :
Dosage : Oral Suspension
Dosage Strength : 200ML
Brand Name : Quik
Approval Date :
Application Number :
Registration Country :
Regulatory Info :
Registration Country :
Brand Name : Flutox
Dosage Form : Syrup
Dosage Strength : 3.4MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country :
Packaging :
Regulatory Info :
Dosage : Syrup
Dosage Strength : 3.4MG
Brand Name : Flutox
Approval Date :
Application Number :
Registration Country :
Regulatory Info :
Registration Country :
Brand Name : Seki
Dosage Form : Syrup
Dosage Strength : 3.54MG/1ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country :
Packaging :
Regulatory Info :
Dosage : Syrup
Dosage Strength : 3.54MG/1ML
Brand Name : Seki
Approval Date :
Application Number :
Registration Country :
ABOUT THIS PAGE
33
PharmaCompass offers a list of Cloperastine Fendizoate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cloperastine Fendizoate manufacturer or Cloperastine Fendizoate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cloperastine Fendizoate manufacturer or Cloperastine Fendizoate supplier.
PharmaCompass also assists you with knowing the Cloperastine Fendizoate API Price utilized in the formulation of products. Cloperastine Fendizoate API Price is not always fixed or binding as the Cloperastine Fendizoate Price is obtained through a variety of data sources. The Cloperastine Fendizoate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cloperastine Fendizoate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cloperastine Fendizoate, including repackagers and relabelers. The FDA regulates Cloperastine Fendizoate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cloperastine Fendizoate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cloperastine Fendizoate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cloperastine Fendizoate supplier is an individual or a company that provides Cloperastine Fendizoate active pharmaceutical ingredient (API) or Cloperastine Fendizoate finished formulations upon request. The Cloperastine Fendizoate suppliers may include Cloperastine Fendizoate API manufacturers, exporters, distributors and traders.
click here to find a list of Cloperastine Fendizoate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Cloperastine Fendizoate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cloperastine Fendizoate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cloperastine Fendizoate GMP manufacturer or Cloperastine Fendizoate GMP API supplier for your needs.
A Cloperastine Fendizoate CoA (Certificate of Analysis) is a formal document that attests to Cloperastine Fendizoate's compliance with Cloperastine Fendizoate specifications and serves as a tool for batch-level quality control.
Cloperastine Fendizoate CoA mostly includes findings from lab analyses of a specific batch. For each Cloperastine Fendizoate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cloperastine Fendizoate may be tested according to a variety of international standards, such as European Pharmacopoeia (Cloperastine Fendizoate EP), Cloperastine Fendizoate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cloperastine Fendizoate USP).